A Phase II trial of Recce Pharmaceutical’s topical skin infection gel has ‘exceeded expectations’, with 93% of patients achieving the primary efficacy endpoint. The Australian company’s ...
The Recce commandos not only faced the terrorist head-on, leaving them no chance, but strived to ensure all survivors were evacuated safely and as fast as possible. Most of the members had key ...
SYDNEY, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), (Recce or the Company) the Company developing a new class of synthetic anti-infectives, today announced it ...
Recce Pharmaceuticals is commercializing a novel synthetic broad-spectrum antibiotic designed to overcome antimicrobial resistance. Its lead compound, RECCE 327, is one of the first entirely new ...
Recce awarded expedited regulatory review status in Indonesia to fast-track progression of trial Company on track to start trial this quarter Special Report: Recce Pharmaceuticals has received ...
The Recce commandos not only faced the terrorist head-on, leaving them no chance, but strived to ensure all survivors were evacuated safely and as fast as possible. Most of the members had key ...